Anbio Share Price

Anbio Share Price

NASDAQ: NNNN | Others
$3.57
-$0.20 (-5.18%) Last updated on 21 Nov, 2026 | 01:45 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Anbio Stock Performance

Open
$3.47
Prev. Close
$3.77
Circuit Range
N/A
Day Range
$3.47 - $3.49
Year Range
$3.11 - $42.83
Volume
354
Average Traded
$3.48

Anbio Share Price Today

As of 22 November 2026, Anbio Biotechnology Class A's share price is $3.57. The stock opened at $3.47, compared to its previous close of $3.77. During today's trading session, Anbio Biotechnology Class A's share price traded between $3.47 and $3.49, with an average price of $3.48. Over the past 52 weeks, the stock has recorded a high of $42.83 and a low of $3.11. In terms of performance, Anbio Biotechnology Class A's share price has declined by 88.80% over the last six months and is down 74.61% on a year-on-year basis.

Anbio Share Price Chart

Line chart of the Anbio price trend over the selected period. The price fell overall, ranging from 3.48 to 3.61, ending at 3.57.
$3.47$3.49
L
Show Current Price
H

Anbio Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$8.65B
Return On Equity (TTM)
N/A
Profit Margin
73.99%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Anbio Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$8.65
Net Profit$6.40
Net Profit Margin73.99%
Income ChangeN/A

Anbio Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets0.0
Current Assets30.24
Total Assets30.24
Non Current Liabilities0.0
Current Liabilities0.09
Total Liabilities0.09
Shareholders' Equity30.16

Anbio Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-6.74
Investing-4.2
Financing6.95

About Anbio

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Anbio Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.46
$3.48
-0.14%
Oct 2026
$6.27
$3.49
-43.80%
Sep 2026
$7.12
$6.21
-21.19%
Aug 2026
$11.75
$7.88
-19.18%
Jul 2026
$12.62
$9.75
-30.85%
Jun 2026
$32.02
$14.10
-55.76%
May 2026
$31.57
$31.88
+13.84%
Apr 2026
$26.45
$28.00
+8.74%
Mar 2026
$23.70
$25.75
-13.46%
Feb 2026
$21.16
$29.75
+45.11%
Jan 2026
$33.44
$20.50
-30.82%
Dec 2025
$36.90
$29.64
+110.81%

Anbio Share Price FAQs